Navigation
banner

All posts by Satish Medicetty

Dr. Medicetty is GTCbio’s President and has a great vision to create impactful platforms that bring together right people to drive the future of science and medicine. He is a biotech entrepreneur and his background includes a unique blend of executive management, business development and scientific expertise. He received a degree (BVSc – equivalent to DVM) in Veterinary Medicine from A.N.G.R.A.University, India. He received a PhD from Kansas State University, Manhattan, KS. Later, he received his MBA from Weatherhead School of Management, CWRU, Cleveland, OH.

2017

Human vs Technology or Human with Technology – What’s better?

Satish Medicetty | November 15th, 2017

This continues to be an interesting question, and I approached it with a different perspective from a recent experience. I just got back from the Society for Neuroscience (SFN) 49th Annual Meeting, which had almost 30,000 attendees. I have been at this meeting many times in the past and yet I am surprised by the…read more

Cogentis Therapeutics is the Winner of the New Company/Technology Pitch Competition at the CNS Diseases Summit

Satish Medicetty | September 21st, 2017

We were truly excited to conduct our inaugural new company/technology pitch competition at last week’s CNS diseases summit in Boston, MA. Four finalists, Orion Biosciences, Cogentis Therapeutics, Neurolucent and Acelot, participated in this fast-paced pitch session that included rating from judges as well as audience. The judges, Christine Brennan from MRL Ventures, Barbara Tate from…read more

Start-up Corner at GTCbio

Satish Medicetty | June 23rd, 2017

GTCbio is undertaking a new initiative to support start-up companies. GTCbio’s “Ready, Set, Grow – New Company / New Technology Pitch Competition” at the focused therapeutic conferences is designed to provide visibility and expert feedback for the participating new companies and technologies. GTCbio conferences provide a unique community of professionals from academia, biotech and pharma…read more

What is the future of graduate students and post-doctoral fellows in life sciences?

Satish Medicetty | April 24th, 2017

At a recent GTCbio conference I had a conversation with a well-known and highly accomplished Professor about his interaction with a group of graduate students. The Professor was apparently invited to give a guest-lecture and it is common to engage with graduate students during these visits. The Professor was sitting on a round table with…read more

How conferences can be transformational platforms?

Satish Medicetty | March 2nd, 2017

A month ago I shared my initial thoughts on how gtcbio is promoting a “Drive Together” concept to change conferences to transformational platforms. The image below will provide a high-level overview of our approach.  All our platforms will be built on key central pillars: content, stakeholders, relationships and connectivity.  Each individual pillar will have its…read more

Changing conferences to transformational platforms

Satish Medicetty | February 2nd, 2017

Few months ago when I acquired GTCbio, a company that develops and organizes conferences, my colleagues and friends were wondering if this was a change in my biotech & pharma career path. However, I see this as a strategic opportunity to create a platform that can discuss new  ideas and technologies to enable transformation of future…read more